John Grohol: “Prior authorizations, at least for atypical antipsychotics prescribed to people with schizophrenia, don’t really help cut costs, and could actually hurt people with this disorder (because of increased discontinuation of the ineffective medications).”
Related Stories
More in Uncategorized
Comments
- Anonymous
Previous post: The clinical years
Next post: The attack on female physicians continues




